Literature DB >> 15119849

Anti-Candida and mode of action of two newly synthesized polymers: a modified poly (methylmethacrylate-co-vinylbenzoylchloride) and a modified linear poly (chloroethylvinylether-co-vinylbenzoylchloride) with special reference to Candida albicans and Candida tropicalis.

Yehia A G Mahmoud1, Magda M Aly.   

Abstract

Polymeric antimicrobial agents represent a new and important direction that is developing in the field of antimicrobial agents. Antimicrobial activity of two newly synthesized polymers: a modified poly (methylmethacrylate-co-vinylbenzoylchloride) and a modified linear poly (chloroethylvinylether-co-vinylbenzoylchloride) have been investigated and found to be active. Both polymers have showed a broad antimicrobial activity against C. albicans and C. tropicalis. Minimal inhibitory concentrations (MIC's) for poly (methylmethacrylate-co-vinylbenzoyl chloride) were 100, 75 and 100 microg/ml in case of C. albicans (ATCC 2091), C. albicans (SC5314) and C. tropicalis, respectively. However, polycholoroethylvinylether-covinylbenzoylchloride inhibited C. albicans (ATCC 2091), C. albicans (SC5314) and C. tropicalis with minimum inhibitory concentration values (MIC's) of 150 microg/ml against the three tested Candida strains. Mode of action studies of both polymers on the medically important yeasts, C. albicans and C. tropicalis revealed that poly (methylmethacrylate-co-vinylbenzoylchloride) induced cytotoxicity, DNA damage, and altered cell permeability and morphology, which was manifested as aggregated and swollen yeast cells (C. albicans ATCC 2091) by fluorescent microscopy examination. Poly (chloroethylvinylether-co-vinylbenzoylchloride) increased cell permeability, and respiration for C. albicans and C. tropicalis. The tested polymers at 50 microg/ml had pronounced effects on C. albicans and C. tropicalis cell wall phosphopeptidomannane, proteins, sugars and phosphorus. Generally, the two polymers proved effective against the tested microorganisms, but growth inhibitory effect varied according to the composition of the polymer active group. Many investigators consider polymeric antimicrobial agents as a potential new approach for enhancing the efficiency of some existing antimicrobial agents, including prolonged activity, reduce their toxicity, as well as reduce the environmental issues associated with product use.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15119849     DOI: 10.1023/b:myco.0000020593.75809.91

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  19 in total

1.  A colorimetric assay of lysogenic induction designed for screening potential carcinogenic and carcinostatic agents.

Authors:  R K Elespuru; M B Yarmolinsky
Journal:  Environ Mutagen       Date:  1979

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Pathogenicity determinants of Candida albicans: potential targets for immunotherapy?

Authors:  R C Matthews
Journal:  Microbiology       Date:  1994-07       Impact factor: 2.777

4.  Formation of a new cell wall by protoplasts of Candida albicans: effect of papulacandin B, tunicamycin and Nikkomycin.

Authors:  M V Elorza; A Murgui; H Rico; F Miragall; R Sentandreu
Journal:  J Gen Microbiol       Date:  1987-08

5.  Effect of primycin on the inner membrane permeability of rat liver mitochondria.

Authors:  L Mészáros; T König; M Paróczai; K Náhm; I Horváth
Journal:  J Antibiot (Tokyo)       Date:  1979-02       Impact factor: 2.649

6.  A carbohydrate-degrading enzyme from Candida albicans: correlation between alpha-glucosidase activity and fungal growth.

Authors:  K Bramono; R Tsuboi; H Ogawa
Journal:  Mycoses       Date:  1995 Sep-Oct       Impact factor: 4.377

7.  The effects of azole and polyene antifungals on the plasma membrane enzymes of Candida albicans.

Authors:  R Surarit; M G Shepherd
Journal:  J Med Vet Mycol       Date:  1987-12

8.  A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly.

Authors:  D J Frost; K D Brandt; D Cugier; R Goldman
Journal:  J Antibiot (Tokyo)       Date:  1995-04       Impact factor: 2.649

Review 9.  The fungal cell wall as a drug target.

Authors:  N H Georgopapadakou; J S Tkacz
Journal:  Trends Microbiol       Date:  1995-03       Impact factor: 17.079

10.  Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity.

Authors:  C S Taft; T Stark; C P Selitrennikoff
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

View more
  1 in total

1.  Exploration of the anticandidal mechanism of Cassia spectabilis in debilitating candidiasis.

Authors:  Angeline Torey; Soundararajan Vijayarathna; Subramanion L Jothy; Sivapragasam Gothai; Yeng Chen; Lachimanan Yoga Latha; Jagat R Kanwar; Saravanan Dharmaraj; Sreenivasan Sasidharan
Journal:  J Tradit Complement Med       Date:  2015-01-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.